20260417-招银国际-中际旭创-300308.SZ-1Q26_earnings_Brighter_than_a_shooting_star_4页_721kb

Innolight (300308 CH) Summary

Core Content and Performance Highlights

Innolight reported a strong first quarter of 2026 (1Q26), with revenue and net profit both exceeding expectations and setting new quarterly highs. Key figures include:

• Revenue: RMB19.5bn, up 192% YoY and 47.3% QoQ, surpassing the Bloomberg consensus of RMB15.4bn.
• Net Profit: RMB5.7bn, up 262% YoY and 56.5% QoQ, surpassing the consensus of RMB4.4bn.
• Gross Margin (GPM): Expanded to 46.1%, up from 44.5% in 4Q25, driven by a better product mix and increased SiPho penetration.

The management emphasized that the strong performance reflects sustained demand and improved execution, with robust capacity expansion in Thailand and effective raw material procurement in a tight supply-demand environment. The analyst maintains a BUY rating with a target price of RMB1,080, based on a 28x 2027E P/E ratio, up from a previous 28x 2026E P/E.

Key Product Trends

• 800G and 1.6T Products: Both saw increased ramp-up, contributing to margin expansion. The growth is broadening across the company's high-end optical portfolio.
• SiPho Penetration: Expected to exceed 50% of shipments in 2026, providing a structural support to margins.
• NPO and XPO: NPO is set for volume production in 2027, while XPO offers broader deployment flexibility across scale-up and scale-out scenarios, with a transmission reach of 100m to 2km.

Financial Overview

Share Performance

• Market Cap: RMB899,557.7 million
• Average 3-month Turnover (RMB mn): 18,372.9 million
• 52-Week High/Low (RMB): 809.61 / 77.61
• Total Issued Shares (mn): 1,111.1 million

Analyst Ratings

• CMBIG Ratings:
  • BUY: Stock with potential return of over 15% over next 12 months.
  • HOLD: Stock with potential return of +15% to -10% over next 12 months.
  • SELL: Stock with potential loss of over 10% over next 12 months.
  • NOT RATED: Stock is not rated by CMBIGM.
  • OUTPERFORM: Industry expected to outperform the relevant broad market benchmark over next 12 months.
  • MARKET-PERFORM: Industry expected to perform in-line with the relevant broad market benchmark over next 12 months.
  • UNDERPERFORM: Industry expected to underperform the relevant broad market benchmark over next 12 months.

Analyst Contact

• Kevin ZHANG: (852) 3761 8727, kevinzhang@cmbi.com.hk
• Aaron GUO: (852) 3916 3715, aaronguo@cmbi.com.hk

Valuation and Growth

• P/E Ratio: Drops from 404.8 in 2023A to 13.6 in 2028E, reflecting improved profitability and growth.
• Gross Profit Margin: Expected to rise from 33.0% in 2023A to 48.5% in 2028E.
• Operating Margin: Projected to increase from 23.3% in 2023A to 44.6% in 2028E.
• Return on Equity (ROE): Increases from 16.6% in 2023A to 53.6% in 2028E.

Liquidity and Capital Structure

• Current Ratio: Rises from 2.6 in 2023A to 5.3 in 2028E, indicating stronger liquidity.
• Cash & Equivalents: Grows from RMB3,317 million in 2023A to RMB112,658 million in 2028E.
• Net Cash from Operations: Increases from RMB1,897 million in 2023A to RMB63,198 million in 2028E.
• Net Change in Cash: Rises from RMB3,234 million in 2023A to RMB112,658 million in 2028E.

Risk and Disclaimer

• The report contains risks and uncertainties.
• The information is not suitable for all investors.
• CMBIGM does not provide individually tailored investment advice.
• Past performance is not indicative of future results.
• The report is for the use of intended recipients only and may not be reproduced, reprinted, sold, redistributed, or published without prior written consent.
• CMBIGM may have conflicts of interest and is not liable for any loss, damage, or expense resulting from reliance on the report.